ABC | Volume 115, Nº2, Agosto 2020

Artigo Original Jardim et al. Tratamento multidisciplinar da hipertensão Arq Bras Cardiol. 2020; 115(2):174-181 Tabela 3 – Variáveis independentemente associadas com controle da pressão arterial (n=1548); Goiânia – Brasil Variáveis Odds Ratio [Intervalo de confiança 95%] Valor de p Diabetes 0,15 [0,11-0,20] <0,001 Idade ≥ 60 anos 1,45 [1,13-1,90] 0,005 Sexo feminino 1,36 [1,09-1,88] 0,022 Consumo de álcool 0,80 [0,56-1,15] 0,183 Tabagismo 1,25 [0,80-1,80] 0,330 Sedentarismo 0,78 [0,60-1,02] 0,053 Tratamento farmacológico 1,12 [0,50-2,47] 0,741 Índice de massa corporal (Kg/m 2 ) 0,97 [0,95-1,01] 0,088 Tempo de acompanhamento (anos) 1,01 [1,00-1,03] 0,098 Número de drogas anti-hipertensivas 0,85 [0,68-1,01] 0,320 Vinculação acadêmica Não há vinculação deste estudo a programas de pós- graduação. Aprovação ética e consentimento informado Este estudo foi aprovado pelo Comitê de Ética do Hospital das Clínicas da Universidade Federal de Goiás sob o número de protocolo 1822-180. Todos os procedimentos envolvidos nesse estudo estão de acordo com a Declaração de Helsinki de 1975, atualizada em 2013. 1. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force onClinical PracticeGuidelines. Hypertension. 2018;71(6):1269- 1324. 2. Mancia G, Fagard R, Narkiewicz K, Rendon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for themanagement of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159-219. 3. Forouzanfar MH, Liu P, Roth GA, NgM, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm hg, 1990-2015. JAMA. 2017;317(2):165-82. 4. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224-60. 5. Blacher J, Levy BI, Mourad JJ, Safar ME, Bakris G. From epidemiological transition tomodern cardiovascular epidemiology: hypertension in the 21st century. Lancet. 2016;388(10043):530-2. 6. Blood Pressure Lowering Treatment Trialists’ Collaboration. Blood pressure- lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet. 2014;384(9943):591-8. 7. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957-67. 8. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441-50. 9. Proia KK, Thota AB, Njie GJ, Finnie RK, Hopkins DP, Mukhtar Q, et al. Team-based care and improved blood pressure control: a community guide systematic review. Am J Prev Med. 2014;47(1):86-99. 10. Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension. Arch Intern Med. 2009;169(19):1748-55. 11. Malachias MVB, Franco RJ, Forjaz CLM, Pierin AMG, Gowdak MMG, Klein MRST, et al. 7th Brazilian Guideline of Arterial Hypertension: chapter 6 - non-pharmacological treatment. Arq Bras Cardiol. 2016;107(3 supl 3):30-4. 12. Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, et al. Hypertension Canada’s 2016 Canadian Hypertension Education ProgramGuidelines for Blood PressureMeasurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Can J Cardiol. 2016;32(5):569-88. 13. Malachias MVB, Gomes MAM, Nobre F, Alessi A, Feitosa AD, Coelho EB. 7th Brazilian Guideline of Arterial Hypertension: chapter 2 - diagnosis and classification. Arq Bras Cardiol. 2016;107(3 supl 3):7-13. 14. Pereira DA, Costa NMSC, Sousa ALL, Jardim PCBV, Zanini CRO. The effect of educational intervention on the disease knowledge of diabetes mellitus patients. Rev Latino-Am Enfermagem. 2012;20(3):478-85. 15. Sousa AL, Jardim PC, Monego ET, Raimundo MS, Lopes KE, Coelho J, et al. Multidisciplinary experience in the approach to the hypertensive patient. Arq Bras Cardiol. 1992;59(1):31-5. 16. Jardim LM, Jardim TV, Souza WK, Pimenta CD, Sousa AL, Jardim PC. Multiprofessional treatment of high blood pressure in very elderly patients. Arq Bras Cardiol. 2017;108(1):53-9. 17. Jardim TV, Inuzuka S, Galvão L, Negretto LAF, Oliveira RO, Sá WF, et al. Multidisciplinary treatment of patients with diabetes and hypertension: experience of a Brazilian center. Diabetes Metab Syndr. 2018;10(3):1-8. 18. Milech A, Angelucci AP, Golbert A, Matheus A, Carrilho AJF, Ramalho AC, et al. Diretrizes da Sociedade Brasileira de Diabetes 2015-2016. São Paulo: A.C. Farmacêutica; 2016. Referências 180